In summary, we demonstrated that circulating levels of serum IGF-I and IGFBP-3 are associated with TDLU count among women with benign breast disease, and that the strongest associations are found among women who have high mammographic density. This evidence concerns the gene IGF1 and breast fibrocystic disease.